InnoCan Pharma Corporation
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well… Read more
InnoCan Pharma Corporation - Asset Resilience Ratio
InnoCan Pharma Corporation (INNPF) has an Asset Resilience Ratio of 14.99% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2017)
This chart shows how InnoCan Pharma Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down InnoCan Pharma Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $167.05K | 14.99% |
| Total Liquid Assets | $167.05K | 14.99% |
Asset Resilience Insights
- Moderate Liquidity: InnoCan Pharma Corporation has 14.99% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
InnoCan Pharma Corporation Industry Peers by Asset Resilience Ratio
Compare InnoCan Pharma Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523 |
Household & Personal Products | 0.13% |
|
Taiyen Biotech Co Ltd
TW:1737 |
Household & Personal Products | 4.80% |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206 |
Household & Personal Products | 24.73% |
|
Hunan Resun Co Ltd
SHE:001218 |
Household & Personal Products | 6.95% |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328 |
Household & Personal Products | 42.83% |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094 |
Household & Personal Products | 0.00% |
|
C&S Paper Co Ltd
SHE:002511 |
Household & Personal Products | 8.72% |
|
Anhui Deli Household Glass Co Ltd
SHE:002571 |
Household & Personal Products | 0.11% |
Annual Asset Resilience Ratio for InnoCan Pharma Corporation (2015–2017)
The table below shows the annual Asset Resilience Ratio data for InnoCan Pharma Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 51.41% | $740.18K | $1.44 Million | -5.46pp |
| 2016-12-31 | 56.87% | $857.05K | $1.51 Million | +4.70pp |
| 2015-12-31 | 52.16% | $927.01K | $1.78 Million | -- |